Physician

Michael Brian Bagwell, D.O.

According to 2025 Medicare claims, Michael Bagwell, D.O. (NPI: 1558306019) practices family practice in the Memphis, TN-MS-AR market, with the plurality of this provider's patient population coming from De Soto, MS. This provider's primary affiliated billing organization is ARCHIPOIMEN PLLC (NPI: 1881119618; TIN: 82-2049599) and primary practice location at 38632-8632. Bagwell is affiliated with the Aledade 79 AL MSSP Enhanced (ACO ID: A4894), participating under the MSSP model.

Bagwell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,777 traditional Medicare patients, billed 29,540 HCPCS/CPT codes, and received $923,484 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,291 prescription claims across 701 beneficiaries totaling $1,042,874 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 339 claims. Open Payments data shows 110 records totaling $2,061. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $154,203 to $923,484. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $376,912 to $1,042,874. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $10,504 to $35,589.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	361	6,534	$154,203
2016	310	5,343	$115,045
2017	653	7,248	$201,513
2018	572	6,942	$228,402
2019	732	10,246	$304,610
2020	823	10,811	$346,270
2021	1,200	13,374	$512,777
2022	1,594	23,209	$756,072
2023	1,583	36,869	$1,147,917
2024	1,777	29,540	$923,484

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	319	4,623	$376,912
2016	299	4,597	$379,091
2017	531	5,786	$463,859
2018	556	9,740	$864,812
2019	601	10,436	$989,369
2020	657	10,404	$1,062,229
2021	720	9,630	$1,022,902
2022	791	9,617	$1,131,516
2023	626	8,923	$1,130,230
2024	701	9,291	$1,042,874

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	92	314	$10,083
2016	78	338	$10,462
2017	71	354	$8,947
2018	114	420	$6,858
2019	111	417	$9,070
2020	98	306	$5,064
2021	57	327	$10,310
2022	53	361	$21,069
2023	51	389	$26,634
2024	39	339	$29,180

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	1,055	1,055	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,427	3,174	$74
G0444	Annual depression screening, 5 to 15 minutes	1,039	1,039	$17
36415	Insertion of needle into vein for collection of blood sample	1,586	4,005	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	1,212	1,774	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	153	5,016	$180,621
Farxiga	Dapagliflozin Propanediol	124	7,358	$128,046
Jardiance	Empagliflozin	105	5,970	$106,551
Xarelto	Rivaroxaban	48	2,460	$45,924
Eliquis	Apixaban	37	2,336	$44,787

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	11	56	$22,813
E0601	Continuous positive airway pressure (cpap) device	Y	12	63	$1,707
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	23	$1,616
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	17	$823
K0003	Lightweight wheelchair	Y	N/R	23	$534

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	110	$2,061	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Brian Bagwell, D.O.?

Tedicare shows public-source Medicare data for Michael Brian Bagwell, D.O. (NPI 1558306019), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Brian Bagwell, D.O. have ACO affiliation data?

Michael Brian Bagwell, D.O. is shown with ACO affiliation data for Aledade 79 AL MSSP Enhanced (MSSP, ACO ID A4894).

What billing organization is linked to Michael Brian Bagwell, D.O.?

Michael Brian Bagwell, D.O. is linked to ARCHIPOIMEN PLLC (billing NPI 1881119618) in the available physician profile data.

Does Michael Brian Bagwell, D.O. have Open Payments data?

Michael Brian Bagwell, D.O. has 110 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.